• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过利用具有独特结构的小分子抑制剂来开发出乙酸盐释放通道,实现了人类 HDAC 同工酶选择性。

Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors.

机构信息

Novartis Institutes for Biomedical Research, 100 Technology Square & 250 Massachusetts Avenue, Cambridge, MA 02139, USA.

出版信息

Bioorg Med Chem. 2011 Aug 1;19(15):4626-34. doi: 10.1016/j.bmc.2011.06.030. Epub 2011 Jun 15.

DOI:10.1016/j.bmc.2011.06.030
PMID:21723733
Abstract

Herein we report the discovery of a family of novel yet simple, amino-acid derived class I HDAC inhibitors that demonstrate isoform selectivity via access to the internal acetate release channel. Isoform selectivity criteria is discussed on the basis of X-ray crystallography and molecular modeling of these novel inhibitors bound to HDAC8, potentially revealing insights into the mechanism of enzymatic function through novel structural features revealed at the atomic level.

摘要

在此,我们报告了一类新型的、简单的、源于氨基酸的 I 类组蛋白去乙酰化酶抑制剂的发现,这类抑制剂通过进入内部乙酸盐释放通道来表现出同工酶选择性。同工酶选择性标准是基于这些新型抑制剂与 HDAC8 结合的 X 射线晶体学和分子建模来讨论的,这可能通过在原子水平上揭示的新结构特征来深入了解酶功能的机制。

相似文献

1
Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors.通过利用具有独特结构的小分子抑制剂来开发出乙酸盐释放通道,实现了人类 HDAC 同工酶选择性。
Bioorg Med Chem. 2011 Aug 1;19(15):4626-34. doi: 10.1016/j.bmc.2011.06.030. Epub 2011 Jun 15.
2
Azetidinones as zinc-binding groups to design selective HDAC8 inhibitors.氮杂环丁酮作为锌结合基团设计选择性 HDAC8 抑制剂。
ChemMedChem. 2009 Dec;4(12):1991-2001. doi: 10.1002/cmdc.200900309.
3
Toward selective histone deacetylase inhibitor design: homology modeling, docking studies, and molecular dynamics simulations of human class I histone deacetylases.迈向选择性组蛋白去乙酰化酶抑制剂设计:人类I类组蛋白去乙酰化酶的同源建模、对接研究及分子动力学模拟
J Med Chem. 2005 Nov 3;48(22):6936-47. doi: 10.1021/jm0505011.
4
Inside HDAC with HDAC inhibitors.与 HDAC 抑制剂一起进入 HDAC。
Eur J Med Chem. 2010 Jun;45(6):2095-116. doi: 10.1016/j.ejmech.2010.02.030. Epub 2010 Feb 14.
5
Structural basis for the design and synthesis of selective HDAC inhibitors.选择性组蛋白去乙酰化酶抑制剂的设计与合成的结构基础。
Bioorg Med Chem. 2013 Jul 1;21(13):3795-807. doi: 10.1016/j.bmc.2013.04.036. Epub 2013 Apr 22.
6
Docking of hydroxamic acids into HDAC1 and HDAC8: a rationalization of activity trends and selectivities.将羟肟酸对接进入 HDAC1 和 HDAC8:对活性趋势和选择性的合理化解释。
J Chem Inf Model. 2009 Dec;49(12):2774-85. doi: 10.1021/ci900288e.
7
Ligand release mechanisms and channels in histone deacetylases.组蛋白去乙酰化酶中的配体释放机制和通道。
J Comput Chem. 2013 Oct 5;34(26):2270-83. doi: 10.1002/jcc.23390. Epub 2013 Jul 27.
8
Novel HDAC6 isoform selective chiral small molecule histone deacetylase inhibitors.新型组蛋白去乙酰化酶 6 同工型选择性手性小分子组蛋白去乙酰化酶抑制剂。
Bioorg Med Chem Lett. 2009 Feb 1;19(3):688-92. doi: 10.1016/j.bmcl.2008.12.045. Epub 2008 Dec 14.
9
Exploring inhibitor release pathways in histone deacetylases using random acceleration molecular dynamics simulations.利用随机加速分子动力学模拟探索组蛋白去乙酰化酶中的抑制剂释放途径。
J Chem Inf Model. 2012 Feb 27;52(2):589-603. doi: 10.1021/ci200584f. Epub 2012 Feb 7.
10
Structural origin of selectivity in class II-selective histone deacetylase inhibitors.II类选择性组蛋白去乙酰化酶抑制剂选择性的结构起源
J Med Chem. 2008 May 22;51(10):2898-906. doi: 10.1021/jm7015254. Epub 2008 Apr 16.

引用本文的文献

1
Binding mechanism and distant regulation of histone deacetylase 8 by PCI-34051.PCI-34051对组蛋白去乙酰化酶8的结合机制及远距离调控
Commun Biol. 2025 Feb 12;8(1):221. doi: 10.1038/s42003-025-07649-0.
2
Anticancer benzimidazole derivatives as inhibitors of epigenetic targets: a review article.作为表观遗传靶点抑制剂的抗癌苯并咪唑衍生物:一篇综述文章。
RSC Adv. 2025 Jan 13;15(2):966-1010. doi: 10.1039/d4ra05014b. eCollection 2025 Jan 9.
3
Rapid Determination of Kinetic Constants for Slow-Binding Inhibitors and Inactivators of Human Histone Deacetylase 8.
快速测定人组蛋白去乙酰化酶 8 的缓慢结合抑制剂和失活剂的动力学常数。
Int J Mol Sci. 2024 May 21;25(11):5593. doi: 10.3390/ijms25115593.
4
Replacement of the hydroxamic acid group in the selective HDAC8 inhibitor PCI-34051.取代选择性 HDAC8 抑制剂 PCI-34051 中的羟肟酸基团。
Bioorg Med Chem Lett. 2024 Aug 1;108:129810. doi: 10.1016/j.bmcl.2024.129810. Epub 2024 May 22.
5
Combined In Silico and In Vitro Analyses to Assess the Anticancer Potential of Thiazolidinedione-Thiosemicarbazone Hybrid Molecules.联合计算机模拟和体外分析评估噻唑烷二酮-硫代缩氨基脲杂合分子的抗癌潜力。
Int J Mol Sci. 2023 Dec 15;24(24):17521. doi: 10.3390/ijms242417521.
6
Electrophilic MiniFrags Revealed Unprecedented Binding Sites for Covalent HDAC8 Inhibitors.亲电小分子 MiniFrags 揭示了共价 HDAC8 抑制剂的前所未有的结合位点。
J Med Chem. 2024 Jan 11;67(1):572-585. doi: 10.1021/acs.jmedchem.3c01779. Epub 2023 Dec 19.
7
HIt Discovery using docking ENriched by GEnerative Modeling (HIDDEN GEM): A novel computational workflow for accelerated virtual screening of ultra-large chemical libraries.基于对接增强生成建模的 HIt 发现(HIDDEN GEM):一种用于加速超大规模化学库虚拟筛选的新型计算工作流程。
Mol Inform. 2024 Jan;43(1):e202300207. doi: 10.1002/minf.202300207. Epub 2023 Dec 19.
8
Intrinsic structural dynamics dictate enzymatic activity and inhibition.内在结构动力学决定酶的活性和抑制。
Proc Natl Acad Sci U S A. 2023 Oct 10;120(41):e2310910120. doi: 10.1073/pnas.2310910120. Epub 2023 Oct 2.
9
Continuous enzyme activity assay for high-throughput classification of histone deacetylase 8 inhibitors.用于组蛋白去乙酰化酶8抑制剂高通量分类的连续酶活性测定
Explor Target Antitumor Ther. 2023;4(3):447-459. doi: 10.37349/etat.2023.00144. Epub 2023 Jun 30.
10
Fragment-Based Discovery of a Novel, Brain Penetrant, Orally Active HDAC2 Inhibitor.基于片段的新型脑渗透性口服活性HDAC2抑制剂的发现
ACS Med Chem Lett. 2022 Sep 6;13(10):1591-1597. doi: 10.1021/acsmedchemlett.2c00272. eCollection 2022 Oct 13.